Last reviewed · How we verify

NCT05746494

The Efficacy of Neural Stimulation in Individuals With Schizophrenia

Completed NA Results posted Last updated 26 February 2025
What this trial tests

NA trial testing tDCS in Schizophrenia in 50 participants. Completed in 1 August 2024.

Timeline
21 November 2022
Primary endpoint
1 August 2024
1 August 2024

Quick facts

Lead sponsorThe University of Texas at Dallas
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposebasic science
Enrollment50
Start date21 November 2022
Primary completion1 August 2024
Estimated completion1 August 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The University of Texas at Dallas

Who can join

Adults 18 to 64, any sex, with Schizophrenia or Schizo Affective Disorder. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

The State Social Paranoia Scale (SSPS) Primary · The assessment was completed before the stimulation and 30 minutes after completion of the active/sham stimulation

Paranoid ideation was measured by the State Social Paranoia Scale (SSPS). Participants indicated how much they agree with each of 20 statements (e.g., "Someone was hostile towards me", "Someone was trying to isolate me") using a 5-point Likert scale (1 = do not agree, 5 = totally agree). Scores range from 20-100, and higher scores represent higher state paranoid ideation.

GroupValue95% CI
Active Visit9.72± 14.61
Sham Visit3.90± 11.56
Ecological Momentary Assessment (EMA)-Based Paranoia Primary · Change in daily paranoia feelings was assessed from the pre-stimulation EMA period (7 days before the stimulation visit) to the post-stimulation EMA period (7 days after the stimulation visit)

Paranoid ideation was measured by Ecological Momentary Assessment (EMA), which involved questions about feelings of paranoia in daily life. The paranoia-related question is as follows: "Since the past alarm, how much have you had thoughts that you really can't trust other people?" The score for this item ranges from 1 to 7, with a higher score indicating a higher level of paranoid thinking.

GroupValue95% CI
EMA-baseline3.78± 1.72
EMA-active3.61± 0.91
EMA-sham3.96± 1.85
Birchwood Social Functioning Scale (SFS) Primary · The assessment was completed 30 minutes after completion of the active/sham stimulation

Social functioning was measured by the Birchwood Social Functioning Scale (SFS). This scale measures social adjustment based on self-reports (4- or 5-point scales), with higher total scores indicating better social functioning (range = 0-223).

GroupValue95% CI
Active Visit114.21± 22.35
Sham Visit114.59± 27.54
Ecological Momentary Assessment (EMA)-Based Social Functioning Primary · Change in daily interactions was assessed from the pre-stimulation EMA period (7 days before the stimulation visit) to the post-stimulation EMA period (7 days after the stimulation visit)

Social functioning was measured by Ecological Momentary Assessment (EMA) (i.e., questions about daily interactions with others). Two subscores were generated: social interaction frequency (score ranges from 0-5, a higher score indicates more frequent social interactions), social interaction motivation and experience (scores range from 1-7, a higher score indicates higher motivations to interact with others and better experiences during these interactions).

Social interaction frequency
GroupValue95% CI
EMA-baseline0.97± 0.76
EMA-active0.91± 0.83
EMA-sham0.92± 0.90
Social interaction motivation and experience
GroupValue95% CI
EMA-baseline3.74± 1.62
EMA-active4.08± 1.68
EMA-sham3.71± 1.62
The Trustworthiness Task Secondary · The assessment was completed 30 minutes after completion of the active/sham stimulation

Paranoid ideation was measured by the Trustworthiness Task. This task requires participants to indicate how much they trust each of 60 grayscale facial stimuli along a 7-point Likert scale (-3 = very untrustworthy, 3 = very trustworthy). Total scores were calculated by averaging across responses and hence varied from -3 to +3, with higher values indicating a greater tendency to trust others.

GroupValue95% CI
Active Visit0.07± 1.16
Sham Visit-0.18± 0.99
The Scrambled-sentences Task (SST) Secondary · The assessment was completed 30 minutes after completion of the active/sham stimulation

Paranoid ideation was measured by the Scrambled-sentences task (SST). This task measures the level of paranoia by asking participants to create sentences of either paranoid or nonparanoid meanings, with a greater percentage indicating a higher level of paranoid interpretation bias (range = 0-1).

GroupValue95% CI
Active Visit0.46± 0.29
Sham Visit0.49± 0.28
The Ambiguous Intentions Hostility Questionnaire (AIHQ) Secondary · The assessment was completed 30 minutes after completion of the active/sham stimulation

Paranoid ideation was measured by the Ambiguous Intentions Hostility Questionnaire (AIHQ). Three subscores were generated: AIHQ (blame) (ranging from 3-16, with a higher score indicating a higher level of blaming tendency), AIHQ (hostility) (ranging from 1-5, with a higher score indicating a higher level of hostility), AIHQ (aggression) (ranging from 1-5, with a higher score indicating a higher level of aggression).

AIHQ (blame)
GroupValue95% CI
Active Visit8.28± 3.07
Sham Visit8.89± 3.22
AIHQ (hostility)
GroupValue95% CI
Active Visit2.09± 0.75
Sham Visit2.35± 0.78
AIHQ (aggression)
GroupValue95% CI
Active Visit1.75± 0.40
Sham Visit1.78± 0.39
The Hostility Scale of the Personality Inventory for DSM-5 (PID-5-HS) Secondary · The assessment was completed 30 minutes after completion of the active/sham stimulation

Paranoid ideation was measured by the Hostility Scale of the Personality Inventory for DSM-5 (PID-5-HS). PID-5-HS contains 10 self-report items assessing pathological hostility. A total score (range from 0-30) was generated to reflect overall hostility level, with higher total scores indicating more hostility.

GroupValue95% CI
Active Visit9.42± 7.56
Sham Visit11.30± 7.57

Sponsor's own description

The purpose of this study is to understand the relationship between psychotic symptoms and social functioning in individuals with schizophrenia spectrum disorders. Our goal is to determine whether stimulating the brain using transcranial Direct Current Stimulation (tDCS) can improve symptoms and daily functioning.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Transcranial Direct Current Stimulation Improves Paranoia and Social Functioning in Schizophrenia: A Randomized Clinical Trial.
    Fan L, Carrico S, Zhu Y, Ackerman RA, et al · · 2025 · cited 2× · PMID 39855408 · DOI 10.1016/j.biopsych.2025.01.011

Verify or expand the search:

Other trials of tDCS

Trials testing the same drug.

Other recruiting trials for Schizophrenia

Currently open trials in the same condition.

Other The University of Texas at Dallas trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05746494.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing